Stericycle, Inc. (NASDAQ:SRCL) Stock Position Lifted by Corient Private Wealth LLC

Corient Private Wealth LLC lifted its holdings in Stericycle, Inc. (NASDAQ:SRCLFree Report) by 52.8% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 10,397 shares of the business services provider’s stock after purchasing an additional 3,591 shares during the quarter. Corient Private Wealth LLC’s holdings in Stericycle were worth $515,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Sachetta LLC bought a new position in shares of Stericycle in the fourth quarter worth $100,000. Robeco Institutional Asset Management B.V. acquired a new stake in shares of Stericycle in the fourth quarter valued at $156,000. First Eagle Investment Management LLC lifted its holdings in shares of Stericycle by 9.5% in the fourth quarter. First Eagle Investment Management LLC now owns 230,975 shares of the business services provider’s stock valued at $11,447,000 after buying an additional 20,101 shares during the period. Heartland Advisors Inc. lifted its holdings in shares of Stericycle by 55.5% in the fourth quarter. Heartland Advisors Inc. now owns 583,545 shares of the business services provider’s stock valued at $29,733,000 after buying an additional 208,256 shares during the period. Finally, Vanguard Personalized Indexing Management LLC lifted its holdings in shares of Stericycle by 14.2% in the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 5,653 shares of the business services provider’s stock valued at $280,000 after buying an additional 705 shares during the period. Institutional investors own 98.82% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently weighed in on the company. Keefe, Bruyette & Woods upped their price objective on Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a report on Tuesday. Truist Financial upped their price objective on Stericycle from $50.00 to $62.00 and gave the company a “hold” rating in a report on Tuesday. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $62.00 target price (down from $69.00) on shares of Stericycle in a report on Tuesday. Wells Fargo & Company upped their target price on Stericycle from $40.00 to $48.00 and gave the company an “underweight” rating in a report on Friday, March 1st. Finally, Robert W. Baird reduced their target price on Stericycle from $62.00 to $55.00 and set a “neutral” rating for the company in a report on Friday, April 26th. One research analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $74.00.

View Our Latest Stock Analysis on Stericycle

Stericycle Stock Down 0.2 %

Shares of Stericycle stock opened at $59.11 on Friday. The stock has a 50-day moving average price of $49.34 and a 200 day moving average price of $49.53. The company has a market cap of $5.48 billion, a P/E ratio of -268.68, a P/E/G ratio of 3.19 and a beta of 1.08. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.55. Stericycle, Inc. has a 1 year low of $37.78 and a 1 year high of $59.45.

Stericycle (NASDAQ:SRCLGet Free Report) last announced its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.03. The firm had revenue of $664.90 million during the quarter, compared to the consensus estimate of $676.42 million. Stericycle had a positive return on equity of 7.31% and a negative net margin of 0.74%. The business’s revenue for the quarter was down 2.8% on a year-over-year basis. During the same period in the prior year, the business earned $0.49 EPS. As a group, analysts expect that Stericycle, Inc. will post 2.32 EPS for the current fiscal year.

Stericycle Company Profile

(Free Report)

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.

Read More

Institutional Ownership by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.